Silexion Therapeutics Corp Quarterly Accounts Payable, Current in USD from Q4 2023 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
Silexion Therapeutics Corp quarterly Accounts Payable, Current history and growth rate from Q4 2023 to Q2 2025.
  • Silexion Therapeutics Corp Accounts Payable, Current for the quarter ending June 30, 2025 was $692K, a 146% increase year-over-year.
Accounts Payable, Current, Quarterly (USD)
Accounts Payable, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2025 $692K +$411K +146% Jun 30, 2025 10-Q 2025-08-12
Q1 2025 $722K Mar 31, 2025 10-Q 2025-05-13
Q4 2024 $929K +$610K +191% Dec 31, 2024 8-K 2025-08-20
Q3 2024 $799K Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $281K Jun 30, 2024 10-Q 2024-08-29
Q4 2023 $319K Dec 31, 2023 8-K 2025-08-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.